NCT06461949: Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray |
|
|
| Recruiting | 3 | 132 | US | Dupilumab | National Institute on Deafness and Other Communication Disorders (NIDCD) | Allergic Fungal Rhinosinusitis (AFRS), Chronic Rhinosinusitis (CRS), Asthma, Nasal Polyps | 12/25 | 03/26 | | |
